HomeStock ScreenerMarkobenz VenturesIntrinsic Value

Markobenz Ventures Intrinsic Value

Markobenz Ventures (NEWTRAC) median intrinsic value is ₹7.78 from 2 valuation models (range ₹3–₹8), vs current price ₹3.89 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. For current market price and key ratios, visit NEWTRAC share price.

Current Stock Price
₹3.89
Primary Intrinsic Value
₹2.63
Market Cap
₹7.4 Cr
+100.0% Upside
Median Value
₹7.78
Value Range
₹3 - ₹8
Assessment
Trading Below Calculated Value
Safety Margin
50.0%

NEWTRAC Valuation Methods Summary — DCF, Graham Number & P/E

Markobenz Ventures intrinsic value across 2 models vs current price ₹3.89 — upside/downside and value range per method. Read NEWTRAC dividend track record for the complete payout history and dividend yield track record.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹2.63 ₹2.37 - ₹2.89 -32.4% Book Value/Share: ₹2.63, P/B: 1.0x
Revenue Multiple Method revenue ₹7.78 ₹7.00 - ₹8.56 +100.0% Revenue/Share: ₹13.68, P/S: 0.8x
Method Types: Earnings Asset DCF Growth Dividend Conservative

NEWTRAC Intrinsic Value vs Market Price — All Valuation Models

Markobenz Ventures fair value range ₹3–₹8 vs current market price ₹3.89 across 2 valuation models. Analyse NEWTRAC promoter holding to track promoter, FII and institutional holdings.

NEWTRAC Intrinsic Value Analysis — Undervalued or Overvalued?

Markobenz Ventures median intrinsic value ₹7.78, current price ₹3.89 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.

What is the intrinsic value of NEWTRAC?

Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Markobenz Ventures (NEWTRAC) is ₹7.78 (median value). With the current market price of ₹3.89, this represents a +100.0% variance from our estimated fair value.

The valuation range spans from ₹2.63 to ₹7.78, indicating ₹2.63 - ₹7.78.

Is NEWTRAC undervalued or overvalued?

Based on our multi-method analysis, Markobenz Ventures (NEWTRAC) appears to be trading below calculated value by approximately 100.0%.

NEWTRAC Financial Health — Key Ratios vs Industry Benchmarks

Markobenz Ventures financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity -140.0% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin -52.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 1.44x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

NEWTRAC Cash Flow Quality — Operating & Free Cash Flow

Markobenz Ventures operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹-16 Cr ₹-16 Cr Negative Cash Flow 3/10
March 2024 ₹3 Cr ₹3 Cr Positive Free Cash Flow 8/10
March 2023 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2022 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2021 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10